# EDGAR Filing Document

**Accession Number:** 0000019617
**File Stem:** 0000950103-26-005891
**Filing Date:** 2026-4
**Character Count:** 6889
**Document Hash:** de802a97d132ea81c497185719a4051c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950103-26-005891.hdr.sgml**: 20260417

**ACCESSION NUMBER**: 0000950103-26-005891

**CONFORMED SUBMISSION TYPE**: 424B3

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260417

**DATE AS OF CHANGE**: 20260417

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293684
- **FILM NUMBER:** 26872308

**BUSINESS ADDRESS:**
- **STREET 1:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMorgan Chase Financial Co. LLC
- **CENTRAL INDEX KEY:** 0001665650
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 475462128
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293684-01
- **FILM NUMBER:** 26872309

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **STREET 2:** FLOOR 21
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179
- **BUSINESS PHONE:** (212) 270-6000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **STREET 2:** FLOOR 21
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179

---

| | |
|:---|:---|
| **Prospectus addendum**<br> *To the prospectus dated April 17, 2026 and<br> the prospectus supplement dated April 17, 2026* | **Registration Statement Nos. 333-293684 and 333-293684-01<br> Dated April 17, 2026<br> Rule 424(b)(3)** |
| **JPMorgan Chase & Co.** | **JPMorgan Chase Financial Company LLC** |

---

JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC have filed with the Securities and Exchange Commission a prospectus dated April 17, 2026 (the "**Prospectus**") and a prospectus supplement dated April 17, 2026 (the "**Prospectus Supplement**"), which, except as set forth below, supersede each prospectus supplement and prospectus previously filed with the Securities and Exchange Commission by JPMorgan Chase & Co. under the registration statements with the following file numbers: 333-199966, 333-177923, 333-155535 and 333-130051 and by JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC under the registration statement with the following file numbers: 333-270004, 333-270004-01, 333-236659, 333-236659-01, 333-222672, 333-222672-01, 333-209682 and 333-209682-01.

With respect to each pricing supplement, reopening supplement, reopening pricing supplement, product supplement or underlying supplement dated on or prior to April 17, 2026 (each, a "**Relevant Supplement**"):

&nbsp;&nbsp;&nbsp;&nbsp;· all references to a prospectus of JPMorgan Chase & Co. and/or JPMorgan
Chase Financial Company LLC dated prior to April 17, 2026 (a "**Previously Filed Prospectus**") (or to any section of any
such Previously Filed Prospectus) should refer instead to the Prospectus (or to the corresponding section of the Prospectus); and

&nbsp;&nbsp;&nbsp;&nbsp;· all references to a prospectus supplement of JPMorgan Chase & Co. and/or
JPMorgan Chase Financial Company LLC dated prior to April 17, 2026 (a "**Previously Filed Prospectus Supplement**") (or
to any section of any such Previously Filed Prospectus Supplement) should refer instead to the Prospectus Supplement (or to the corresponding
section of the Prospectus Supplement);

*provided* that:

&nbsp;&nbsp;&nbsp;&nbsp;· unless otherwise specified in a future supplement or addendum, in connection
with the specific notes referred to in any Relevant Supplement, any discussion in connection with tax treatment or tax consequences of
the relevant notes in the Prospectus Supplement shall be disregarded;

&nbsp;&nbsp;&nbsp;&nbsp;· all references to the "Forms of Securities — Book-Entry System"
section of a prospectus dated prior to November 14, 2011 and all references to the "The Depositary" section of a prospectus
supplement dated prior to November 14, 2011 shall be deemed to refer to the section entitled "Forms of Securities — Book-Entry
System" in the Prospectus; and

&nbsp;&nbsp;&nbsp;&nbsp;· in connection with the specific notes of JPMorgan Chase & Co. referred
to in any Relevant Supplement (the "**Relevant Notes** "), all references to the "indenture" or "Indenture"
of JPMorgan Chase & Co. (the "**Indenture**") and to any of its terms or any terms of the notes governed by the Indenture
are to the Indenture dated May 25, 2001, between JPMorgan Chase & Co. and Deutsche Bank Trust Company Americas (formerly Bankers Trust
Company), as trustee, as amended by any supplemental indenture that, by its terms and as specified in the Previously Filed Prospectus
and Previously Filed Prospectus Supplement, applies to the Relevant Notes. Accordingly, unless otherwise specified in a future supplement
or addendum, the description of the Indenture and of the provisions of the notes governed by the Indenture contained in the Previously
Filed Prospectus and Previously Filed Prospectus Supplement is not superseded and remains in effect.

JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC will, and other affiliates of JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC may, use this prospectus addendum and the Prospectus and Prospectus Supplement in connection with reopening of notes or market-making transactions of notes originally issued under any prospectus dated prior to April 17, 2026 and any prospectus supplement dated prior to April 17, 2026.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this prospectus addendum or any Relevant Supplement, the Prospectus Supplement or the Prospectus. Any representation to the contrary is a criminal offense.

***The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.***

![](image_002.jpg)

April 17, 2026

### Attached PDF Documents

**Attachment 1:** `crt_dp245099-424b3pamm.pdf`

_No text found in this document._